Amaran Biotech Debuts at Healthcare+ EXPO Taiwan 2025

Amaran Biotech is pleased to announce our participation in the 7th Vaccine World Asia Congress 2025 – South East Asia, where we will introduce our proprietary AB-801(QS-21) vaccine adjuvant and share insights into how it accelerates vaccine commercialization. Presentation Details: Join us at this premier regional vaccine event to explore how Amaran Biotech addresses the QS-21 paradox and empowers partners with superior adjuvant technology for next-generation vaccine development. 🔗 Event Website: Vaccine World Asia Congress 2025 – South East Asia

Amaran Biotech will participate in BioJapan 2025 from October 8–10 at Pacifico Yokohama, together with BPIPO(Biotechnology and Pharmaceutical Industries Promotion Office), DCB(Development Center for Biotechnology), and fellow biotech companies from Taiwan. As one of Asia’s most influential biotech and pharma exhibitions, BioJapan brings together exhibitions, seminars, and partnering meetings, serving as a key platform for global collaboration. 📍 You can find us at the Taiwan Pavilion, Booth B-77.🤝 Book a meeting with us by searching “Amaran” on the BioJapan partnering platform, or contact us directly at service@amaranbiotech.com. We look forward to meeting our partners and exploring new opportunities in Yokohama.

The highly anticipated annual biotechnology event — BIO Asia–Taiwan 2025 Exhibition— will be held from July 24 to 27 at the Taipei Nangang Exhibition Center. Amaran Biotech is proud to debut its new brand identity and vision, showcasing major advancements in aseptic filling line, adjuvant technologies, and global partnerships. Visit us at Booth M726, located in the CDMO zone — we warmly welcome industry partners for dialogue and collaboration. As a one-stop Contract Development and Manufacturing Organization (CDMO), Amaran Biotech provides integrated solutions encompassing vaccine adjuvant AB-801 (QS-21), drug substance manufacturing, and aseptic filling of drug products. With the implementation of a […]

Amaran Biotech, a leading Taiwanese CDMO (Contract Development & Manufacturing Organization) offering comprehensive pharmaceutical development and manufacturing solutions, is making its debut at BioJapan 2024 in Yokohama from October 9 to 11. The company is participating as part of Taiwan’s Biotechnology and Pharmaceutical Industries Promotion Office (BPIPO) delegation. Amaran Biotech will showcase its services at the Taiwan Pavilion (Booth No. B-56), including its vaccine adjuvant AB-801 (QS-21), drug substance manufacturing, drug product manufacturing, and stability study and analytical science services. Visitors are invited to meet with Amaran Biotech's representatives at the event.

BIO Asia–Taiwan 2024, an international gathering jointly organized by the global Biotechnology Innovation Organization (BIO) and the Taiwan Bio Industry Organization (Taiwan BIO); will be held from July 24th to 28th at the Taipei Nangang Exhibition Center. Amaran Biotech’s booth(#M413) will be located at CDMO (Contract Development and Manufacturing Organization) zone, please visit us and meet with our representatives.

The world's largest biotechnology industry event "BIO International Convention 2023" will be held at the Boston Convention & Exhibition Center on June 5-8. Amaran Biotech, is invited by the Biotechnology and Pharmaceutical Industries Promotion Office, Ministry of Economic Affairs (BPIPO, MOEA) and the Taiwan External Trade Development Council (TAITRA), will jointly exhibit at the "Taiwan Pavilion".